<DOC>
	<DOCNO>NCT00638261</DOCNO>
	<brief_summary>Adalimumab , fully human anti-tumor necrosis factor ( TNF ) monoclonal antibody approve treatment moderate severe psoriasis . However , portion case adalimumab induce reduction psoriasis area severity index ( PASI ) 75 % great , consider gold standard treatment efficacy . In study aim determine randomize half-side comparison whether initial narrowband UVB-311nm phototherapy accelerate improve clearance skin lesion adalimumab-treated patient .</brief_summary>
	<brief_title>Primary UVB-311nm Adalimumab Psoriasis Patients</brief_title>
	<detailed_description>Patients moderate severe psoriasis schedule receive standard treatment course adalimumab ( load dose 80 mg thereafter 40 mg s.c. biweekly ) expose UVB-311nm phototherapy randomize body half ( left right ; head exempt ) 3 x per week six week and/or complete response ( define reduction PASI &lt; 3 ) . PASI score , patient visual analogue score ( VAS ) therapeutic response , patient VAS severity skin lesion assess weekly ; follow-up visit month 3 , 6 , 12 . Paired Wilcoxon test difference PASI patient VAS score do ; Fischer exact test apply determine difference complete remission , PASI reduction &gt; 90 % , &gt; 75 % and/or 50 % body sit .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Psoriasis patient schedule treatment adalimumab . Pregnancy lactation History skin cancer Presence history malignant skin tumor Dysplastic melanocytic nevus syndrome Antinuclear antibody ( dsDNA , Ro/SSA , La/SSB ) Autoimmune disorder Lupus erythematosus Dermatomyositis Photosensitive diseases porphyria , chronic actinic dermatitis , Xeroderma pigmentosum , basal cell nevus syndrome , others General poor health status</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Psoriasis</keyword>
	<keyword>Biologic</keyword>
	<keyword>Adalimumab</keyword>
	<keyword>Narrow-band UVB</keyword>
	<keyword>phototherapy</keyword>
	<keyword>half-side comparison</keyword>
</DOC>